2[ No authors listed ]. Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Arthritis Rheum, 1999, 42: 1785-1796.
3Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35:630-640.
4Ikeda Y, Fujimoto T, Ameno M, et al. Relationship between lupus nephritis activity and the serum level of soluble VCAM-1. Lupus,1998, 7: 347-354.
5Mrowka C, Sieberth HG. Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure.Clin Nephrol, 1995, 43:288-296.
1Bombardier C, Gladman DD, Urowitz MB, et al. Derixalion of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Artbritis Rheum. 1992. 35: 630-640.
2[No authors listed].Guidelines for referral and management of systemic lupus erythematosus in adults.American Collgeg of Rlteumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines.Arthritis Rheum.1999,42:1785-1796.
3Morwka C,Sieberth HG.Detection of circulating adhesion molecules ICAM-1.VCAM-1 and E-selectin in Wegener's granulomatosis.systemic lupus erythematosus and chronic renal failure .Clin Nephrol,1995,43:288-296.
4Kawasaki K, Yaoita E. Yamamoto T, et al.Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J Immunol, 1993. 150:1074-1083.
5Birdsall HH,Lane C,Ramse MN,et al.Induction of VCAM-1 and ICAM-1 on human neural cells and mechanisms of mononuclear leukocyte adherence.J Immunol,1992,148:2717-2723.
6Amel-Kashipaz MR, Huggins ML, Lanyon P, Robins A, et al. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8 (-) and CD8 (+) T cells in systemic lupus erythematosus. J Autoimmun, 2001, 17: 155-163.
7Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum,1982, 25: 1271-1277.
8Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35: 630-640.
9Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med, 1994,179: 1109-1118.
10Jonuleit H, Schmitt E, Stassen M, et al. Identification and functional characterization of human CD4 (+) CD25 (+) T cells with regulatory properties isolated from peripheral blood. J Exp Med, 2001, 193:1285-1294.
